New Zealand markets open in 3 hours 14 minutes

Canntab Therapeutics Limited (PILL.CN)

Canadian Sec - Canadian Sec Real-time price. Currency in CAD
Add to watchlist
0.00500.0000 (0.00%)
As of 02:07PM EDT. Market open.
Currency in CAD

Valuation measures4

Market cap (intra-day) 194.54k
Enterprise value 2.07M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.65
Price/book (mrq)N/A
Enterprise value/revenue 28.22
Enterprise value/EBITDA -1.30

Trading information

Stock price history

Beta (5Y monthly) 1.41
52-week change 3-66.67%
S&P500 52-week change 323.49%
52-week high 30.0200
52-week low 30.0050
50-day moving average 30.0050
200-day moving average 30.0054

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 538.91M
Implied shares outstanding 638.91M
Float 838.68M
% held by insiders 113.74%
% held by institutions 10.00%
Shares short (15 Apr 2024) 4391
Short ratio (15 Apr 2024) 4N/A
Short % of float (15 Apr 2024) 4N/A
Short % of shares outstanding (15 Apr 2024) 4N/A
Shares short (prior month 15 Mar 2024) 4391

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 408 Mar 2016
Last split factor 21:200
Last split date 320 Apr 2018

Financial highlights

Fiscal year

Fiscal year ends N/A
Most-recent quarter (mrq)N/A

Profitability

Profit margin 0.00%
Operating margin (ttm)831.74%

Management effectiveness

Return on assets (ttm)-69.60%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)73.48k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -3.03M
Net income avi to common (ttm)-3.36M
Diluted EPS (ttm)-0.0900
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)16.81k
Total cash per share (mrq)0
Total debt (mrq)1.9M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.11
Book value per share (mrq)-0.06

Cash flow statement

Operating cash flow (ttm)-1.4M
Levered free cash flow (ttm)-612.49k